EEF1A2 and cervical carcinoma: Through an integrated repository portal for tumor-immune system interactions database analysis: There was no significant difference between the expression of eEF1A2 protein and clinical stage in cervical cancer (P = .106) (Fig. 8A); There was no significant difference between the expression of eEF1A2 protein and pathological grade in cervical cancer (P = .549) (Fig. 8B); There was no statistical significance between the expression of eEF1A2 protein and the survival of patients with cervical cancer (P = .448) (Fig. 8C).